1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

11 Dec 2024
Admin
News Article

CU Medicine and CTTQ Collaborate to Strengthen Pharma Innovations in Hong Kong

Collaboration will accelerate the translation of groundbreaking biomedical research into new diagnostic tests and treatments. The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) has entered into a strategic partnership with Chia Tai Tianqing Pharmaceutical Group Co. (CTTQ), a leading Chinese pharmaceutical company integral to Sino Biopharm.

This landmark Cooperation Framework Agreement aims to leverage the combined strengths of mainland China and Hong Kong in pharmaceutical innovation, research, talent development, and the commercialisation of medical products.

The collaboration will accelerate the translation of groundbreaking biomedical research into new diagnostic tests and treatments, providing patients quicker access to advanced healthcare solutions. Furthermore, it supports the development of Hong Kong as a pharmaceutical innovation hub in Asia and the Pacific.

The partnership will encompass various collaborative endeavours, including:

Clinical Trials: Implementation of Phase I to Phase III clinical trials in Hong Kong and across Asia
Commercialisation: Exploration of opportunities for commercialising CUHK-developed drugs and medical devices through licensing or startup investments
Research Funding: Joint establishment of funding schemes to support innovative research projects
Talent Development: Collaborative efforts to enhance learning and exchange between CU Medicine students and CTTQ researchers
Academic Conferences: Organisation of annual academic conferences to foster knowledge sharing.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!